Full Article here.
In Mountain View, California, a breath test called Metabolomx completed a clinical trial that shows its breath test can find lung cancer with an 83 percent accuracy rate. The test can also differentiate between types of cancer. Normally, this would require a biopsy. There are many cases of false positives for lung cancer, and this new device will effectively determine if a patient has cancer without exposing them to harsh radiation, none of which are approved by Medicare. Chemical results of a tumor’s metabolism are dissolved in the blood, and can end up in the breath. This is why trained dogs can identify breath samples from patients with lung cancer with a 98 percent accuracy rate. Paul Rhodes, the founder ans the CEO of Metabolomx will continue test trials to make the test more sensitive to biomarkers and get the accuracy rate up to 90 percent. This rise in accuracy will hopefully make the test available in the markets.
No comments:
Post a Comment